Tango Therapeutics (TNGX) Change in Receivables (2023)
Tango Therapeutics (TNGX) recorded quarterly Change in Receivables of -$2.0 million in Q1 2023.
Tango Therapeutics (TNGX) Change in Receivables (2023) Analysis & Trends
Tango Therapeutics' Change in Receivables history runs 1 years deep, the most recent figure standing at -$2.0 million for Q1 2023.
- In Q1 2023, Change in Receivables changed N/A year-over-year to -$2.0 million; the TTM figure through Dec 2023 stood at -$2.0 million (changed N/A YoY), while the FY2023 annual figure was -$2.0 million, changed N/A from the prior year.
- Change in Receivables was -$2.0 million for Q1 2023 at Tango Therapeutics.
- In the past five years, Change in Receivables ranged from a high of -$2.0 million in Q1 2023 to a low of -$2.0 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -4.08 Mn |
| 10 | Tango Therapeutics | 4.05 Bn | 3.67 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -2.00 Mn |
| Mar 31, 2023 | -2.00 Mn |